Elon Musk’s Neuralink says it has FDA approval for study of brain implants in humans
Elon Musk’s Neuralink says it has FDA approval for study of brain implants in humans May 25 (Reuters) – Elon Musk’s brain-implant company
Tag : Fda Approval
Krystal gets first FDA approval for redosable gene therapy, rare skin disease
Krystal gets first FDA approval for redosable gene therapy, rare skin disease Published: May 22, 2023 By Tristan Manalac BioSpace The FDA
4 min read
Lawsuits endanger FDA role on approvals
Lawsuits endanger FDA role on approvals By Jon Bigelow While media attention has focused on the availability of abortions, take note: contradictory
AI & the FDA
The use of artificial intelligence (AI) in healthcare has been growing rapidly in recent years, and AI-enabled medical devices are playing a
3 min read
Abortion Clerical Errors
Republicans are in a weird state of flux and mostly can't agree on a cohesive message. Can we say "Republicans in disarray!" or
3 min read
Abortion Pill To Stay On Market (FOR NOW) With Entirely Nonsensical Restrictions
Late last night, three-judge panel for the Fifth Circuit stayed (partially) the decision last week from Judge Matthew J. Kacsmaryk, which ruled that
NICE Backs PTC’s gene therapy for ultra-rare pediatric disease
NICE Backs PTC’s gene therapy for ultra-rare pediatric disease Published: Mar 24, 2023 By Tristan Manalac BioSpace England’s National Institute
7 min read
Are Psychedelics a New Paradigm or Business as Usual?
Back in the spine-tingling hysteria of the dotcom boom in the late 1990’s, when investors threw dump trucks of money at dotcom startups, I sat with
4 min read
The Psychedelics Finance Crunch Seen in the SXSW Funhouse Mirror
When I last came to SXSW, Austin’s high rent version of Mardi Gras, in the ancient mid 90s, it was all about the bands. Times change. This year, as
Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100 Treating Alcohol Use Disorder
Company plans to initiate phase I/IIa in-human clinical trials in Q2 2023 Tel Aviv, Israel / Vancouver, Canada, March 16, 2023 (GLOBE NEWSWIRE)
Neuralink, other brain-chip makers face long road to FDA approval
Neuralink, other brain-chip makers face long road to FDA approval By Marisa Taylor March 2 (Reuters) – Neuralink, founded in 2016, has yet to
2 min read
FDA Approves Iyuzeh (latanoprost ophthalmic solution) for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-Angle Glaucoma or Ocular Hypertension
In continuation of my update on LatanoprostThea Pharma, Inc. (“Thea”), the U.S. subsidiary of Europe’s leading independent pharmaceutical
2 min read
FDA Approves Rezlidhia (olutasidenib) for Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation
Rigel Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of Rezlidhia (olutasidenib) capsules for the
3 min read
FDA Approves Krazati (adagrasib) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a targeted oncology company, announced the U.S. Food and Drug Administration (FDA) approval
3 min read
FDA Approves Olpruva (sodium phenylbutyrate) for Patients with Urea Cycle Disorders
In continuation of my update on Phenyl butyrate Acer Therapeutics Inc. and its collaboration partner, RELIEF THERAPEUTICS Holding SA